People with diabetic retinopathy. Diabetic retinopathy
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group will receive curcumin capsule for 8 weeks. curcumin capsule is used once a day with lunch. Intervention 2: Control group:Patients in this gro
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Desire to cooperate and sign informed consent form after full knowledge of the goals and method of implementation of the study Age between 40 to 70 years old People with diabetic retinopathy without insulin
Exclusion criteria
Exclusion criteria: Receiving insulin Cases of chronic diseases such as cardiovascular, renal and hepatic disorders Malabsorption syndrome and inflammatory bowel disease (Crohn's disease, celiac sproctomy, short stomach and biliary tract jejuni-ileal syndrome) Having certain physiological conditions like pregnancy and breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum level of methylglyoxal. Timepoint: First of study and in the end of study. Method of measurement: Elisa. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum levels of Pentosidine. Timepoint: At the beginning of the study and 8 weeks later. Method of measurement: Elisa.;Serum level of Carboxymehtyllyzine. Timepoint: At the beginning of the study and 8 weeks later. Method of measurement: Elisa.;Serum level of tumor necrosis factor alpha. Timepoint: At the beginning of the study and 8 weeks later. Method of measurement: Elisa. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNima Radkhah
Tabriz University of Medical Sciences
Outcome results
None listed